NO953874L - Farmasöytisk preparat inneholdende lipofile legemidler - Google Patents
Farmasöytisk preparat inneholdende lipofile legemidlerInfo
- Publication number
- NO953874L NO953874L NO953874A NO953874A NO953874L NO 953874 L NO953874 L NO 953874L NO 953874 A NO953874 A NO 953874A NO 953874 A NO953874 A NO 953874A NO 953874 L NO953874 L NO 953874L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparation
- preparation containing
- lipophilic drugs
- containing lipophilic
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Abstract
Farmasøytisk preparat som har en form som er egnet for transmukosal adminis- trasjon og inneholder progesteron og/eller 17-p-østradiol som en aktiv bestanddel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19939301171A SE9301171D0 (sv) | 1993-04-07 | 1993-04-07 | Pharmaceutical composition containing lipophilic drugs |
PCT/SE1994/000258 WO1994022426A1 (en) | 1993-04-07 | 1994-03-23 | Pharmaceutical composition containing lipophilic drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO953874D0 NO953874D0 (no) | 1995-09-29 |
NO953874L true NO953874L (no) | 1995-09-29 |
Family
ID=20389517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953874A NO953874L (no) | 1993-04-07 | 1995-09-29 | Farmasöytisk preparat inneholdende lipofile legemidler |
Country Status (18)
Country | Link |
---|---|
US (1) | US5514673A (no) |
EP (1) | EP0693922A1 (no) |
JP (1) | JPH08508478A (no) |
CN (1) | CN1120311A (no) |
AU (1) | AU6514694A (no) |
BR (1) | BR9406566A (no) |
CA (1) | CA2159209A1 (no) |
CZ (1) | CZ260195A3 (no) |
FI (1) | FI954767A0 (no) |
HU (1) | HUT73229A (no) |
IS (1) | IS4145A (no) |
NO (1) | NO953874L (no) |
NZ (1) | NZ263891A (no) |
PL (1) | PL310992A1 (no) |
SE (1) | SE9301171D0 (no) |
SG (1) | SG52435A1 (no) |
SK (1) | SK119895A3 (no) |
WO (1) | WO1994022426A1 (no) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9403389D0 (sv) * | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
CN1044321C (zh) * | 1994-11-18 | 1999-07-28 | 北京蕾波制药厂 | 治疗妇女更年期综合征的药物组合物 |
FR2777784B1 (fr) * | 1998-04-27 | 2004-03-19 | Arepa | Composition pharmaceutique a base d'estrogene et de progesterone |
US6599883B1 (en) | 1998-10-30 | 2003-07-29 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of xylitol |
US20020151732A1 (en) * | 2001-01-05 | 2002-10-17 | Claes Ohlsson | Estrogen receptors |
US10004684B2 (en) * | 2001-02-14 | 2018-06-26 | Gw Pharma Limited | Pharmaceutical formulations |
GB2381194A (en) * | 2001-09-07 | 2003-04-30 | Gw Pharmaceuticals Ltd | Pharmaceutical formulations |
FR2827516B1 (fr) * | 2001-07-19 | 2003-09-19 | Servier Lab | Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone |
US20040213837A1 (en) * | 2002-08-05 | 2004-10-28 | Sankaram Mantripragada | Oil-core compositions for the sustained release of hydrophobic drugs |
EP1820494B1 (en) | 2003-06-13 | 2010-01-13 | Skendi Finance, Ltd. | Microparticles consisting of estradiol and cholesterol |
EP1488785A1 (de) * | 2003-06-18 | 2004-12-22 | B. Braun Melsungen Ag | Ölemulsion zur postnatalen Hormonsubstitution |
ATE319426T1 (de) | 2003-11-11 | 2006-03-15 | Mattern Udo | Nasenformulierung mit kontrollierter freisetzung von sexualhormonen |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
AU2006249349B2 (en) * | 2005-05-26 | 2012-01-12 | Teva Women's Health, Inc. | Oral dosage forms comprising progesterone and methods of making and using the same |
US10016442B2 (en) * | 2005-06-16 | 2018-07-10 | Allergan Pharmaceuticals International Limited | Estrogen compositions for vaginal administration |
CN101232869B (zh) * | 2005-06-16 | 2016-03-02 | 沃纳奇尔科特有限责任公司 | 局部给药的凝胶组合物 |
CA2664427C (en) | 2006-10-04 | 2012-06-05 | M & P Patent Aktiengesellschaft | Controlled release delivery system for nasal application of neurotransmitters |
TW201138782A (en) | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
CN101856360A (zh) * | 2010-06-08 | 2010-10-13 | 玉门中汇农业发展有限公司 | 一种用于山羊发情调控的孕酮复合制剂 |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
AR086400A1 (es) | 2011-05-13 | 2013-12-11 | Trimel Pharmaceuticals Corp | Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
WO2016018993A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053489A (en) * | 1971-04-21 | 1977-10-11 | Pierre Charles Wirth | Oestratriene diethers |
US4078060A (en) * | 1976-05-10 | 1978-03-07 | Richardson-Merrell Inc. | Method of inducing an estrogenic response |
US4096254A (en) * | 1976-05-10 | 1978-06-20 | Richardson-Merrell Inc. | Method of treating the symptoms of menopause and osteoporosis |
US4383993A (en) * | 1980-05-30 | 1983-05-17 | University Of Kentucky Research Foundation | Nasal dosage forms containing natural female sex hormones |
US4396615A (en) * | 1981-06-24 | 1983-08-02 | Duke University | Method of treating androgen-related disorders |
US4596795A (en) * | 1984-04-25 | 1986-06-24 | The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services | Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives |
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US4742046A (en) * | 1984-08-03 | 1988-05-03 | Medisearch S.A. | Methods and compositions for inhibiting the infectious activity of viruses |
WO1990006120A1 (en) * | 1988-12-01 | 1990-06-14 | Schering Corporation | Compositions for transdermal delivery of estradiol |
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
CA2013755C (en) * | 1989-04-05 | 1993-11-30 | Simon Benita | Medicinal emulsions |
CH677886A5 (no) * | 1989-06-26 | 1991-07-15 | Hans Georg Prof Dr Weder | |
SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
US5115805A (en) * | 1990-02-23 | 1992-05-26 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
-
1993
- 1993-04-07 SE SE19939301171A patent/SE9301171D0/xx unknown
-
1994
- 1994-03-23 AU AU65146/94A patent/AU6514694A/en not_active Abandoned
- 1994-03-23 WO PCT/SE1994/000258 patent/WO1994022426A1/en not_active Application Discontinuation
- 1994-03-23 NZ NZ263891A patent/NZ263891A/en unknown
- 1994-03-23 PL PL94310992A patent/PL310992A1/xx unknown
- 1994-03-23 CN CN94191658A patent/CN1120311A/zh active Pending
- 1994-03-23 EP EP94912718A patent/EP0693922A1/en not_active Withdrawn
- 1994-03-23 SK SK1198-95A patent/SK119895A3/sk unknown
- 1994-03-23 JP JP6521975A patent/JPH08508478A/ja active Pending
- 1994-03-23 CA CA002159209A patent/CA2159209A1/en not_active Abandoned
- 1994-03-23 HU HU9502933A patent/HUT73229A/hu unknown
- 1994-03-23 BR BR9406566A patent/BR9406566A/pt not_active Application Discontinuation
- 1994-03-23 CZ CZ952601A patent/CZ260195A3/cs unknown
- 1994-03-24 IS IS4145A patent/IS4145A/is unknown
- 1994-04-07 US US08/224,164 patent/US5514673A/en not_active Expired - Fee Related
- 1994-05-23 SG SG1996004517A patent/SG52435A1/en unknown
-
1995
- 1995-09-29 NO NO953874A patent/NO953874L/no unknown
- 1995-10-06 FI FI954767A patent/FI954767A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2159209A1 (en) | 1994-10-13 |
JPH08508478A (ja) | 1996-09-10 |
SK119895A3 (en) | 1997-03-05 |
FI954767A (fi) | 1995-10-06 |
HU9502933D0 (en) | 1995-11-28 |
AU6514694A (en) | 1994-10-24 |
IS4145A (is) | 1994-10-08 |
WO1994022426A1 (en) | 1994-10-13 |
CZ260195A3 (en) | 1996-01-17 |
PL310992A1 (en) | 1996-01-22 |
NZ263891A (en) | 1996-08-27 |
SE9301171D0 (sv) | 1993-04-07 |
NO953874D0 (no) | 1995-09-29 |
CN1120311A (zh) | 1996-04-10 |
EP0693922A1 (en) | 1996-01-31 |
SG52435A1 (en) | 1998-09-28 |
US5514673A (en) | 1996-05-07 |
HUT73229A (en) | 1996-07-29 |
BR9406566A (pt) | 1996-02-06 |
FI954767A0 (fi) | 1995-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO953874L (no) | Farmasöytisk preparat inneholdende lipofile legemidler | |
KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
KR960706344A (ko) | 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne) | |
MY100721A (en) | Therapeutic agent. | |
AR029159A1 (es) | Preparacion farmaceutica, envase que la contiene y uso en la preparacion de un medicamento util en la terapia de reemplazo hormonal | |
AR004391A1 (es) | Formulacion de liberacion controlada para farmacos basicos escasamente solubles. | |
ES2088312T3 (es) | Formulacion de liberacion controlada que contiene tramadol. | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
PT99340A (pt) | Processo para a preparacao de composicoes farmaceuticas anticoncepcionais contendo um estrogenio em mistura com 16-metileno-17 alfa-acetoxi-19-nor-4-pregneno-3,20-diona para administracao por via transdermica e dispositivo para a realizacao da administracao | |
NO912001L (no) | Buccal tablett med hurtig utlevering. | |
BR9812803A (pt) | Uma cápsula dupla para administração de princìpios ativos em terapias múltiplas | |
ATE202280T1 (de) | Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung | |
BR0014159A (pt) | Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional | |
BR9611802A (pt) | Composições farmacêuticas | |
ATE427103T1 (de) | Orale verabreichung von adenosin analogen | |
MY106242A (en) | Pharmaceutical composition for the prevention of sexually transmitted diseases. | |
BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
ATE292453T1 (de) | Antivirale arznei | |
ATE202926T1 (de) | Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung | |
BR9802537A (pt) | Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
KR890001564A (ko) | 약학적 투여 단위 | |
CA2431397A1 (en) | Self emulsifying lipid matrix (selm) | |
DK0871453T3 (da) | Farmaceutisk kombinationspræparat til hormonal kontraception |